Biofil Chemicals and Pharmaceuticals Limited (BOM:524396)

Market Cap	584.72M -22.0%
Revenue (ttm)	314.78M -6.3%
Net Income	27.86M +399.6%
EPS	1.71 +402.9%
Shares Out	16.27M
PE Ratio	21.01
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,344
Open	35.27
Previous Close	35.10
Day's Range	35.03 - 37.20
52-Week Range	25.60 - 50.69
Beta	0.51
Analysts	n/a
Price Target	n/a
Earnings Date	May 30, 2026

About BOM:524396

Biofil Chemicals and Pharmaceuticals Limited engages in manufacturing and trading of pharmaceuticals in India. It operates through Pharmaceutical and Chemical divisions. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and packaging solutions. It also provides job work service for manufacturing pharmaceutical drugs. Biofil Chemicals and Phar...

• Industry: Pharmaceutical Preparations
• Founded: 1985
• Employees: 26
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524396

Financial Performance

In fiscal year 2026, BOM:524396's revenue was 314.78 million, a decrease of -6.27% compared to the previous year's 335.82 million. Earnings were 27.86 million, an increase of 399.55%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 18, 2026

Data Sources Report a data error